Related Experiment Video

Updated: Mar 20, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Health Economics Methodologies Involving Parkinson's Disease Treatment in China

W Low1, S Azmi1, S L Yee1

  • 1Azmi Burhani Consulting, Petaling Jaya, Malaysia.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K

Related Experiment Videos

Last Updated: Mar 20, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Abnormal cell wall structure caused by boron nutrient imbalance in orchards could affect psyllid feeding behaviour, resulting in epidemic variation of Asian citrus psyllid.

Plant biology (Stuttgart, Germany)·2024

Association between plant nutrients, the development of Huanglongbing and abnormal growth symptoms in navel orange.

Plant biology (Stuttgart, Germany)·2021

Too Young to Undergo Temporal Artery Biopsy? Calciphylaxis-Related Anterior Ischemic Optic Neuropathy.

Neuro-ophthalmology (Aeolus Press)·2019

Subretinal fibrosis is associated with fundus pulverulentus in pseudoxanthoma elasticum.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2018

Health-seeking behaviour among patients with faecal incontinence in a Malaysian academic setting.

The Medical journal of Malaysia·2018

What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia?

The Medical journal of Malaysia·2017

Why Bayesian Nonparametric Models Should Be a First-Line Approach for Health State Valuations.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Individualized Prediction of Patient-Defined Treatment Success to Support Patient-Centered Clinical Decision-Making.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Sleep and fatigue/energy bolt-ons for the EQ-5D-3L and EQ-5D-5L: a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Cost-Effectiveness of Telisotuzumab Vedotin-tllv for Previously Treated High c-Met Protein-Overexpressing Nonsquamous Non-Small Cell Lung Cancer in the United States.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Cost-effectiveness of insulin regimens and insulin types for adults with type 1 diabetes: a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Health Utilities and Costs for Multiple Sclerosis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Multiple paths to privatisation in healthcare? Comparing England and Italy beyond the public-private divide.

Health economics, policy, and law·2026

The Economic Burden of HDV in Italy: Evaluating the Potential Impact and Effects of Bulevirtide for Chronic HDV Infection.

Clinical drug investigation·2026

Why the 2025 Nobel Prize in Economics Matters at the Bedside: Innovation, Institutions, and Hospitalist Leadership.

Journal of general internal medicine·2026

Speed over Value: Korea's Recent Overhaul in Pharmaceutical Pricing and Reimbursement.

Applied health economics and health policy·2026

Variation in Medicare Part D and Part B drug spending among older adults with Alzheimer's disease and related dementias.

Innovation in aging·2026

Analysis of Factors Influencing Drug Prices Differently in Official Drug Pricing and Cost-Effectiveness Evaluation.

Journal of market access & health policy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us